IAN HARROW CONSULTING LTD

Their core work

Ian Harrow Consulting is a specialist UK private consultancy focused on life sciences informatics, particularly the intersection of computational biomolecular research and pharmaceutical drug discovery workflows. The firm brings expert knowledge in making HPC and exascale computing tools accessible and useful to biotech and pharma industry users — acting as a bridge between academic tool developers and industrial adopters. Their sustained participation across both phases of the BioExcel Centre of Excellence indicates a long-term advisory role in connecting computational biology infrastructure to real drug discovery use cases. As a small, agile consultancy, they contribute targeted domain expertise rather than large research teams.

What they specialise in

How they've shifted over time

In the first BioExcel phase (2015–2018) no specific keywords were recorded, pointing to a broad biomolecular research infrastructure focus without explicit pharmaceutical or computing specialisation. By BioExcel-2 (2019–2022) the keyword profile sharpened substantially — Drug Discovery, Exascale, HPC, and HPDA all appear, showing a clear shift toward applying next-generation computing infrastructure to industrial life science problems. The trajectory is from general biomolecular computing support toward targeted pharmaceutical informatics and exascale-ready drug discovery tooling.

Ian Harrow Consulting is moving deeper into the application layer — connecting exascale and HPC infrastructure to concrete drug discovery workflows — making them increasingly relevant to pharma and biotech companies evaluating computational biology adoption.

How they like to work

Ian Harrow Consulting participates exclusively as a consortium partner — they have never led a project — which is consistent with a boutique consultancy providing specialist input rather than project management capacity. Both projects are within the same BioExcel ecosystem, suggesting they build deep, long-term relationships within a focused network rather than diversifying across many different consortia. With 14 partners across 8 countries in just two projects, they operate within medium-to-large Centres of Excellence where their niche expertise adds specific value.

Built a network of 14 unique consortium partners across 8 countries entirely through the BioExcel Centre of Excellence, meaning their connections are concentrated in the European computational biology and HPC research community. Geographic spread across 8 countries is solid for just two projects and reflects BioExcel's pan-European consortium structure.

What sets them apart

Ian Harrow Consulting occupies a rare position as a private SME consultancy embedded inside a flagship EU research infrastructure — most BioExcel partners are universities or research institutes. This gives them credibility with both academic tool developers and industrial life science companies, a combination that is genuinely hard to find. For consortium builders, they offer an industry-facing perspective and pharmaceutical domain knowledge without the overhead of engaging a large CRO or pharma partner.

Highlights from their portfolio

• BioExcel
  Entry into one of the first EU Centres of Excellence for HPC in life sciences, securing the largest single funding award (EUR 183,750) and establishing the consultancy's foothold in the European computational biomolecular research ecosystem.
• BioExcel-2
  Continuation into the exascale era with explicit drug discovery and HPDA scope, demonstrating that the consortium trusted Ian Harrow Consulting enough to renew the partnership and extend it toward pharmaceutical industry applications.